HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

About 1 in 10 people may be resistant to GLP-1 drugs, Stanford researchers report

Louis Nervegna · Apr 13, 2026 · ♥ 2 reactions · 0 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)
AI summary & key facts

A Stanford Medicine news item says GLP-1 medications may not work well for a notable share of people and that genetic testing could help match patients to the right drugs sooner.

1 in 10 people may have resistance to GLP1 drugs.

#glp1HD

GLP-1 medications may not work well for a significant portion of the population, a Stanford Medicine researcher and her colleagues found. Genetic testing could help patients get on the right drugs faster.

#stanford#genetics
← newer: Vitamin C plus E did not blunt resistance training gains in older: Greek yogurt matched whey protein for adolescent athletes' p →